HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 279, Issue 27, 28756-28765, July 2, 2004

This Article Full Text Full Text (PDF) All Versions of this Article: 279/27/28756    most recent M313310200v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Breit, A. Articles by Bouvier, M. Search for Related Content PubMed PubMed Citation Articles by Breit, A. Articles by Bouvier, M. Social Bookmarking                      What's this?

Hetero-oligomerization between ₂- and ₃-Adrenergic Receptors Generates a -Adrenergic Signaling Unit with Distinct Functional Properties^*

Andreas Breit, Monique Lagacé, and Michel Bouvier, Holds a Canada Research Chair in Signal Transduction and Molecular Pharmacology

From the Département de Biochimie et Groupe de Recherche sur le Système Nerveux Autonome, Université de Montréal, Montréal, Québec H3C 3J7, Canada

The ability of the closely related ₂- and ₃-adrenergic receptors (AR) to form hetero-oligomers was assessed by bioluminescence resonance energy transfer. Quantitative bioluminescence resonance energy transfer titration curves revealed that the ₂AR has identical propensity to hetero-oligomerize with the ₃AR than to form homo-oligomers. To determine the influence of heterooligomerization, a HEK293 cell line stably expressing an excess of ₃AR over ₂AR was generated so that all ₂AR are engaged in hetero-oligomerization with ₃AR, providing a tool to study the effect of hetero-oligomerization on ₂AR function in the absence of any ₂AR homooligomer. The hetero-oligomerization had no effect on the ligand binding properties of various ₂AR ligands and did not affect the potency of isoproterenol to stimulate adenylyl cyclase. Despite the unaltered ligand binding properties of the _2/3AR hetero-oligomer, the stable association of the ₂AR with the ₃AR completely blocked agonist-stimulated internalization of the ₂AR. Given that the ₃AR is resistant to agonist-promoted endocytosis, the results indicate that the ₃AR acted as a dominant negative of the ₂AR endocytosis process. Consistent with this notion, the _2/3AR hetero-oligomer displayed a lower propensity to recruit -arrestin-2 than the ₂AR. The hetero-oligomerization also led to a change in G protein coupling selectivity. Indeed, in contrast to ₂AR and ₃AR, which regulate adenylyl cyclase and extracellular signal-regulated kinase activity through a coupling to G_s and G_i/o, no G_i/o coupling was observed for the _2/3AR hetero-oligomer. Together, these results demonstrate that hetero-oligomerization between ₂AR and ₃AR forms a -adrenergic signaling unit that possesses unique functional properties.

Received for publication, December 5, 2003 , and in revised form, April 6, 2004.

^* This work was supported in part by grants from the Canadian Institute for Health Research and from the Heart and Stroke Foundation of Canada. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Supported by a post-doctoral fellowship from AstraZeneca (Montréal).

To whom correspondence should be addressed. Tel.: 514-343-6372; Fax: 514-343-2210; E-mail: michel.bouvier{at}umontreal.ca.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				B. Lagane, K. Y. C. Chow, K. Balabanian, A. Levoye, J. Harriague, T. Planchenault, F. Baleux, N. Gunera-Saad, F. Arenzana-Seisdedos, and F. Bachelerie CXCR4 dimerization and {beta}-arrestin-mediated signaling account for the enhanced chemotaxis to CXCL12 in WHIM syndrome Blood, July 1, 2008; 112(1): 34 - 44. [Abstract] [Full Text] [PDF]

				A. Chakera, R. M. Seeber, A. E. John, K. A. Eidne, and D. R. Greaves The Duffy Antigen/Receptor for Chemokines Exists in an Oligomeric Form in Living Cells and Functionally Antagonizes CCR5 Signaling through Hetero-Oligomerization Mol. Pharmacol., May 1, 2008; 73(5): 1362 - 1370. [Abstract] [Full Text] [PDF]

				A. Kern, D. Hubbard, A. Amano, and G. D. Bryant-Greenwood Cloning, Expression, and Functional Characterization of Relaxin Receptor (Leucine-Rich Repeat-Containing G Protein-Coupled Receptor 7) Splice Variants from Human Fetal Membranes Endocrinology, March 1, 2008; 149(3): 1277 - 1294. [Abstract] [Full Text] [PDF]

				Y. Jiang, L. A. Borrelli, Y. Kanaoka, B. J. Bacskai, and J. A. Boyce CysLT2 receptors interact with CysLT1 receptors and down-modulate cysteinyl leukotriene dependent mitogenic responses of mast cells Blood, November 1, 2007; 110(9): 3263 - 3270. [Abstract] [Full Text] [PDF]

				E. Stefan, S. Aquin, N. Berger, C. R. Landry, B. Nyfeler, M. Bouvier, and S. W. Michnick Quantification of dynamic protein complexes using Renilla luciferase fragment complementation applied to protein kinase A activities in vivo PNAS, October 23, 2007; 104(43): 16916 - 16921. [Abstract] [Full Text] [PDF]

				F. F. Hamdan, M. D. Rochdi, B. Breton, D. Fessart, D. E. Michaud, P. G. Charest, S. A. Laporte, and M. Bouvier Unraveling G Protein-coupled Receptor Endocytosis Pathways Using Real-time Monitoring of Agonist-promoted Interaction between beta-Arrestins and AP-2 J. Biol. Chem., October 5, 2007; 282(40): 29089 - 29100. [Abstract] [Full Text] [PDF]

				M. V. Mikhailova, P. R. Mayeux, A. Jurkevich, W. J. Kuenzel, F. Madison, A. Periasamy, Y. Chen, and L. E. Cornett Heterooligomerization between Vasotocin and Corticotropin-Releasing Hormone (CRH) Receptors Augments CRH-Stimulated 3',5'-Cyclic Adenosine Monophosphate Production Mol. Endocrinol., September 1, 2007; 21(9): 2178 - 2188. [Abstract] [Full Text] [PDF]

				M. Roumy, C. Lorenzo, S. Mazeres, S. Bouchet, J.-M. Zajac, and C. Mollereau Physical Association between Neuropeptide FF and {micro}-Opioid Receptors as a Possible Molecular Basis for Anti-opioid Activity J. Biol. Chem., March 16, 2007; 282(11): 8332 - 8342. [Abstract] [Full Text] [PDF]

				S. M. Hanson, E. V. Gurevich, S. A. Vishnivetskiy, M. R. Ahmed, X. Song, and V. V. Gurevich Each rhodopsin molecule binds its own arrestin PNAS, February 27, 2007; 104(9): 3125 - 3128. [Abstract] [Full Text] [PDF]

				A. Breit, K. Wolff, H. Kalwa, H. Jarry, T. Buch, and T. Gudermann The Natural Inverse Agonist Agouti-related Protein Induces Arrestin-mediated Endocytosis of Melanocortin-3 and -4 Receptors J. Biol. Chem., December 8, 2006; 281(49): 37447 - 37456. [Abstract] [Full Text] [PDF]

				S. C. Prinster, T. G. Holmqvist, and R. A. Hall {alpha}2C-Adrenergic Receptors Exhibit Enhanced Surface Expression and Signaling upon Association with beta2-Adrenergic Receptors J. Pharmacol. Exp. Ther., September 1, 2006; 318(3): 974 - 981. [Abstract] [Full Text] [PDF]

				A. Breit, K. Gagnidze, L. A. Devi, M. Lagace, and M. Bouvier Simultaneous Activation of the {delta} Opioid Receptor ({delta}OR)/Sensory Neuron-Specific Receptor-4 (SNSR-4) Hetero-Oligomer by the Mixed Bivalent Agonist Bovine Adrenal Medulla Peptide 22 Activates SNSR-4 but Inhibits {delta}OR Signaling Mol. Pharmacol., August 1, 2006; 70(2): 686 - 696. [Abstract] [Full Text] [PDF]

				B. Boivin, C. Lavoie, G. Vaniotis, A. Baragli, L.-R. Villeneuve, N. Ethier, P. Trieu, B. G. Allen, and T. E. Hebert Functional {beta}-adrenergic receptor signalling on nuclear membranes in adult rat and mouse ventricular cardiomyocytes Cardiovasc Res, July 1, 2006; 71(1): 69 - 78. [Abstract] [Full Text] [PDF]

				R. Hayashi, S. Osada, M. Yoshiki, D. Sugiyama, I. Fujita, Y. Hamasaki, and H. Kodama Superoxide Production in Human Neutrophils Is Enhanced by Treatment with Transmembrane Peptides Derived from Human Formyl Peptide Receptor J. Biochem., June 1, 2006; 139(6): 981 - 988. [Abstract] [Full Text] [PDF]

				C. L. Piscitelli, T. E. Angel, B. W. Bailey, P. Hargrave, E. A. Dratz, and C. M. Lawrence Equilibrium between Metarhodopsin-I and Metarhodopsin-II Is Dependent on the Conformation of the Third Cytoplasmic Loop J. Biol. Chem., March 10, 2006; 281(10): 6813 - 6825. [Abstract] [Full Text] [PDF]

				J. C. Goin and N. M. Nathanson Quantitative Analysis of Muscarinic Acetylcholine Receptor Homo- and Heterodimerization in Live Cells: REGULATION OF RECEPTOR DOWN-REGULATION BY HETERODIMERIZATION J. Biol. Chem., March 3, 2006; 281(9): 5416 - 5425. [Abstract] [Full Text] [PDF]

				S. Milasta, J. Pediani, S. Appelbe, S. Trim, M. Wyatt, P. Cox, M. Fidock, and G. Milligan Interactions between the Mas-Related Receptors MrgD and MrgE Alter Signalling and Trafficking of MrgD Mol. Pharmacol., February 1, 2006; 69(2): 479 - 491. [Abstract] [Full Text] [PDF]

				C. Hague, S. E. Lee, Z. Chen, S. C. Prinster, R. A. Hall, and K. P. Minneman Heterodimers of {alpha}1B- and {alpha}1D-Adrenergic Receptors Form a Single Functional Entity Mol. Pharmacol., January 1, 2006; 69(1): 45 - 55. [Abstract] [Full Text] [PDF]

				K. G. Harikumar, M. M. Morfis, C. S. Lisenbee, P. M. Sexton, and L. J. Miller Constitutive Formation of Oligomeric Complexes between Family B G Protein-Coupled Vasoactive Intestinal Polypeptide and Secretin Receptors Mol. Pharmacol., January 1, 2006; 69(1): 363 - 373. [Abstract] [Full Text] [PDF]

				F. Huttenrauch, B. Pollok-Kopp, and M. Oppermann G Protein-coupled Receptor Kinases Promote Phosphorylation and {beta}-Arrestin-mediated Internalization of CCR5 Homo- and Hetero-oligomers J. Biol. Chem., November 11, 2005; 280(45): 37503 - 37515. [Abstract] [Full Text] [PDF]

				W. Zhu, X. Zeng, M. Zheng, and R.-P. Xiao The Enigma of {beta}2-Adrenergic Receptor Gi Signaling in the Heart: The Good, the Bad, and the Ugly Circ. Res., September 16, 2005; 97(6): 507 - 509. [Full Text] [PDF]

				S. C. Prinster, C. Hague, and R. A. Hall Heterodimerization of G Protein-Coupled Receptors: Specificity and Functional Significance Pharmacol. Rev., September 1, 2005; 57(3): 289 - 298. [Abstract] [Full Text] [PDF]

				S. Wilson, G. Wilkinson, and G. Milligan The CXCR1 and CXCR2 Receptors Form Constitutive Homo- and Heterodimers Selectively and with Equal Apparent Affinities J. Biol. Chem., August 5, 2005; 280(31): 28663 - 28674. [Abstract] [Full Text] [PDF]

				W.-Z. Zhu, K. Chakir, S. Zhang, D. Yang, C. Lavoie, M. Bouvier, T. E. Hebert, E. G. Lakatta, H. Cheng, and R.-P. Xiao Heterodimerization of {beta}1- and {beta}2-Adrenergic Receptor Subtypes Optimizes {beta}-Adrenergic Modulation of Cardiac Contractility Circ. Res., August 5, 2005; 97(3): 244 - 251. [Abstract] [Full Text] [PDF]

				F. F. Hamdan, M. Audet, P. Garneau, J. Pelletier, and M. Bouvier High-Throughput Screening of G Protein-Coupled Receptor Antagonists Using a Bioluminescence Resonance Energy Transfer 1-Based {beta}-Arrestin2 Recruitment Assay J Biomol Screen, August 1, 2005; 10(5): 463 - 475. [Abstract] [PDF]

				C. S. Kearn, K. Blake-Palmer, E. Daniel, K. Mackie, and M. Glass Concurrent Stimulation of Cannabinoid CB1 and Dopamine D2 Receptors Enhances Heterodimer Formation: A Mechanism for Receptor Cross-Talk? Mol. Pharmacol., May 1, 2005; 67(5): 1697 - 1704. [Abstract] [Full Text] [PDF]